Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Olema Pharmaceuticals, Inc. (OLMA) has a Wall Street consensus price target of $43.38, based on estimates from 7 covering analysts. With the stock currently trading at $24.20, this represents a potential upside of +79.3%. The company has a market capitalization of $1.66B.
Analyst price targets range from a low of $38.00 to a high of $48.00, representing a 23% spread in expectations. The median target of $44.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, OLMA trades at a trailing P/E of -11.0x. Analysts expect EPS to grow -26.6% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how OLMA stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for OLMA is $43.38, representing 79.3% upside from the current price of $24.2. With 7 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
OLMA has a consensus rating of "Buy" based on 7 Wall Street analysts. The rating breakdown is predominantly bullish, with 7 Buy/Strong Buy ratings. The consensus 12-month price target of $43.38 implies 79.3% upside from current levels.
OLMA's current price is $24.2 with a consensus target of $43.38 (79.3% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $48 for OLMA, while the most conservative target is $38. The consensus of $43.38 represents the median expectation. These targets typically reflect 12-month expectations.
OLMA is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month OLMA stock forecast based on 7 Wall Street analysts shows a consensus price target of $43.38, with estimates ranging from $38 (bear case) to $48 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on OLMA, with a "Buy" consensus rating and $43.38 price target (79.3% upside). 7 of 7 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
OLMA analyst price targets range from $38 to $48, a 23% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $43.38 consensus represents the middle ground.